Quantum BioPharma Ltd. (QNTM)
2.82
-0.12
(-4.08%)
USD |
NASDAQ |
Oct 12, 16:00
2.81
-0.01
(-0.35%)
After-Hours: 20:00
Quantum BioPharma Debt to Equity Ratio : 0.1212 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1212 |
| March 31, 2026 | 1.462 |
| December 31, 2025 | 0.271 |
| September 30, 2025 | 0.2956 |
| June 30, 2025 | 0.6018 |
| March 31, 2025 | 0.2233 |
| December 31, 2024 | 0.0719 |
| September 30, 2024 | 0.0229 |
| June 30, 2024 | 0.0571 |
| March 31, 2024 | 0.0519 |
| December 31, 2023 | 0.0256 |
| September 30, 2023 | 0.0245 |
| June 30, 2023 | 0.0269 |
| March 31, 2023 | 0.0224 |
| December 31, 2022 | 0.0169 |
| September 30, 2022 | 0.0154 |
| June 30, 2022 | 0.0119 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0118 |
| December 31, 2021 | 0.0103 |
| September 30, 2021 | 0.0066 |
| June 30, 2021 | 0.007 |
| March 31, 2021 | 0.007 |
| December 31, 2020 | 0.0141 |
| September 30, 2020 | 0.0323 |
| June 30, 2020 | 0.0438 |
| March 31, 2020 | 0.0534 |
| December 31, 2019 | 0.0438 |
| September 30, 2019 | 0.0352 |
| June 30, 2019 | 0.0321 |
| March 31, 2019 | 0.0049 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Numinus Wellness, Inc. | -0.4102 |
| Cocrystal Pharma, Inc. | 1.284 |
| Edesa Biotech, Inc. | 0.00 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| Invion Ltd. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.39M |
| Total Liabilities (Quarterly) | 8.298M |
| Shareholders Equity (Quarterly) | 7.949M |
| Current Ratio | 1.200 |
| Net Debt Paydown Yield | 0.23% |